In white adipose tissue of male rodents with T2DM, SGLT2 inhibition similarly increased the expression of NRF1 and PGC1α as it did in the heart, which was associated with an increase in mitochondrial DNA, a marker of mitochondrial content (136, 138). Here, PPARGC1A is linked to type 2 diabetes mellitus.